ArticleFrontiers in microbiology2026
Convergent GenX biodegradation by genomically designed and functionally screened synthetic bacterial consortia.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
GenX (hexafluoropropylene oxide dimer acid) has been introduced as a replacement for legacy polyfluoroalkyl substances (PFASs) compounds; however, accumulating evidence indicates this C6 ether-PFAS may exhibit comparable toxicity to PFOA while persisting in contaminated water supplies. Biological remediation offers genuine mineralization potential but has been constrained by the exceptional stability of carbon-fluorine bonds. Here, we demonstrate that synthetic bacterial consortia assembled through rational genomic design (GENIA) or microfluidic selection (Community G) achieve rapid GenX biodegradation through metabolic complementarity among functionally specialized taxa. Both consortia removed >80% of GenX within 3 days (GENIA: 94.6%; Community G: 80.6%), with defluorination confirmed by fluoride release (82.6 and 69.6%, respectively). First-order kinetic modeling yielded rate constants of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.